(S)-Methyl 4-(4-(4-(4-((7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)butanamido)-1-methyl-1H-pyrrole-2-carboxamido)phenyl)-1-methyl-1H-pyrrole-2-carboxylate

ID: ALA2321905

Chembl Id: CHEMBL2321905

PubChem CID: 71606413

Max Phase: Preclinical

Molecular Formula: C36H38N6O7

Molecular Weight: 666.74

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1cc(-c2ccc(NC(=O)c3cc(NC(=O)CCCOc4cc5c(cc4OC)C(=O)N4CCC[C@H]4C=N5)cn3C)cc2)cn1C

Standard InChI:  InChI=1S/C36H38N6O7/c1-40-20-23(15-30(40)36(46)48-4)22-9-11-24(12-10-22)39-34(44)29-16-25(21-41(29)2)38-33(43)8-6-14-49-32-18-28-27(17-31(32)47-3)35(45)42-13-5-7-26(42)19-37-28/h9-12,15-21,26H,5-8,13-14H2,1-4H3,(H,38,43)(H,39,44)/t26-/m0/s1

Standard InChI Key:  OVVDVKXCZRNFHP-SANMLTNESA-N

Associated Targets(Human)

WI-38 (2654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caulobacter vibrioides (128 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 666.74Molecular Weight (Monoisotopic): 666.2802AlogP: 5.20#Rotatable Bonds: 11
Polar Surface Area: 145.49Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 2#RO5 Violations (Lipinski): 3
CX Acidic pKa: 13.64CX Basic pKa: 4.06CX LogP: 3.71CX LogD: 3.71
Aromatic Rings: 4Heavy Atoms: 49QED Weighted: 0.17Np Likeness Score: -0.57

References

1. Rahman KM, Jackson PJ, James CH, Basu BP, Hartley JA, de la Fuente M, Schatzlein A, Robson M, Pedley RB, Pepper C, Fox KR, Howard PW, Thurston DE..  (2013)  GC-targeted C8-linked pyrrolobenzodiazepine-biaryl conjugates with femtomolar in vitro cytotoxicity and in vivo antitumor activity in mouse models.,  56  (7): [PMID:23514599] [10.1021/jm301882a]
2. Joseph AM, Nahar K, Daw S, Hasan MM, Lo R, Le TBK, Rahman KM, Badrinarayanan A..  (2022)  Mechanistic insight into the repair of C8-linked pyrrolobenzodiazepine monomer-mediated DNA damage.,  13  (12.0): [PMID:36561066] [10.1039/d2md00194b]

Source